| 2025年中报 | 2024年年报 | 2024年中报 | |
|---|---|---|---|
| 营业收入(元) | |||
| 医药贸易(元) | 42,730,810.50 | 101,844,482.40 | 72,278,266.35 |
| 医药制造(元) | 1,249,405,742.76 | 2,342,227,629.01 | 1,283,671,740.95 |
| 营业成本(元) | |||
| 医药贸易(元) | 32,818,280.87 | 85,760,525.67 | 64,347,278.47 |
| 医药制造(元) | 506,444,722.93 | 982,320,250.38 | 518,641,446.37 |
| 毛利(元) | |||
| 医药贸易(元) | 9,912,529.63 | 16,083,956.73 | 7,930,987.88 |
| 医药制造(元) | 742,961,019.83 | 1,359,907,378.63 | 765,030,294.58 |
| 毛利率(%) | |||
| 医药贸易(%) | 23.20 | 15.79 | 10.97 |
| 医药制造(%) | 59.47 | 58.06 | 59.60 |
| 收入构成(%) | |||
| 医药贸易(%) | 3.31 | 4.17 | 5.33 |
| 医药制造(%) | 96.69 | 95.83 | 94.67 |
| 毛利构成(%) | |||
| 医药贸易(%) | 1.32 | 1.17 | 1.03 |
| 医药制造(%) | 98.68 | 98.83 | 98.97 |